Source: c19study.com
The studies continue to roll out, and there has been very positive results in pre and post exposure as well as early treatment of confirmed COVID-19 patients ( near 100%). There is also considerable efficacy (62%) when treating late. Most studies concur.
Check out c19study.com for the up to date tally on what is evolving. The site is live and constantly updated.
See Related:
Hydroxychloroquine significantly lowers COVID-19 death rate, Henry Ford Health study finds
NY Study: Risk Factors for Mortality in Patients with COVID-19 in New York City
Chronic treatment with hydroxychloroquine and SARS-CoV-2 infection.